Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 18 July 2025

Sec. Gynecological Oncology

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1649631

Correction: CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situ

This article is a correction to:

  1. CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situ

    1. Read original article
Rong ZengRong Zeng1Yulin GuoYulin Guo2Miao ZouMiao Zou2Chaonan WangChaonan Wang2Xufeng Wu*Xufeng Wu2*
  • 1Department of Gynecologic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 2Cervical Cancer Control Center of Hubei Province. Maternal and Child Health Hospital of Hubei Province, Wuhan, China

A Correction on
CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situ

By Zeng R, Guo Y, Zou M, Wang C and Wu X (2025). Front. Oncol. 15:1571130. doi: 10.3389/fonc.2025.1571130

In the published article, there was an error in Affiliation 1. Instead of “Department of Gynecologic Oncology, Hubei Cancer Hospital, Wuhan, China”, it should be “Department of Gynecologic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: AIS, AIS-plus-CIN, hysterectomy, residual disease, conization, negative margin

Citation: Zeng R, Guo Y, Zou M, Wang C and Wu X (2025) Correction: CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situ. Front. Oncol. 15:1649631. doi: 10.3389/fonc.2025.1649631

Received: 18 June 2025; Accepted: 30 June 2025;
Published: 18 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Zeng, Guo, Zou, Wang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xufeng Wu, end1eHVmZW5nQDE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.